I don’t think there will be much revenue for awhile. They applied the loss lead sales to the US as well but it’s part of the foundations that will help in the longer run. PCK and RAP didn’t do any revenue either to get to their valuations so it seems to be about getting traction in a market that puts value behind the stock based on future potential. Still, I’m only speculating and I personally put a higher value here based on current developments comparative to its “peer” Akili.
TD1 Charts, page-120
-
- There are more pages in this discussion • 2,288 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TD1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.295M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 24843912 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 26527964 | 12 |
View Market Depth
| Last trade - 16.12pm 04/10/2024 (20 minute delay) ? |
| TD1 (ASX) Chart |
Day chart unavailable